share_log

Eiger BioPharmaceuticals | 424B5: Prospectus

SEC announcement ·  Apr 18, 2019 16:32
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more